Cite
HARVARD Citation
Holstein, S. et al. (2017). Updated analysis of CALGB (Alliance) 100104 assessing lenalidomide versus placebo maintenance after single autologous stem-cell transplantation for multiple myeloma: a randomised, double-blind, phase 3 trial. Lancet. 4 (9), pp. e431-e442. [Online].